A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Recap by typeshit. Full story at BusinessWorld Online.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
A Facebook post says Ozempic's Medicare price drops 71% as negotiated rates on 15 drugs, including Wegovy and Trelegy, take effect.
A BusinessWorld piece on tirzepatide, semaglutide and retatrutide and where each stands with the FDA. Little detail was available beyond the topic.
Loading…